RMS-YMHomo sapiens (Human)Cancer cell line
Also known as: RMSYM
AI Summary
No AI-generated summary available for this cell line.
Basic Information
Database ID | CVCL_A792 |
---|---|
Species | Homo sapiens (Human) |
Tissue Source | Urachus[UBERON:UBERON_0002068] |
Donor Information
Age | 2 |
---|---|
Age Category | Pediatric |
Sex | Male |
Disease Information
Disease | Embryonal rhabdomyosarcoma |
---|---|
Lineage | Soft Tissue |
Subtype | Embryonal Rhabdomyosarcoma |
OncoTree Code | ERMS |
DepMap Information
Source Type | RIKEN |
---|---|
Source ID | ACH-002048_source |
Known Sequence Variations
Type | Gene/Protein | Description | Zygosity | Note | Source |
---|---|---|---|---|---|
MutationSimple | BCOR | p.Arg1163Ter (c.3487C>T) | Homozygous | - | Unknown |
Haplotype Information (STR Profile)
Short Tandem Repeat (STR) profile for cell line authentication.
Amelogenin
X,Y
CSF1PO
11
D13S317
10,11
D16S539
11
D5S818
12,14
D7S820
10,11
TH01
9
TPOX
11
vWA
18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines
Loading gene expression data...
Publications
Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls.
Linardic C.M.
Front. Oncol. 3:183.1-183.12(2013).
Cetuximab promotes anticancer drug toxicity in rhabdomyosarcomas with EGFR amplification in vitro.
Kitagawa Y., Morikawa Y., Kuroda T.
Oncol. Rep. 30:1081-1086(2013).
Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development.
Pritchard-Jones K., Kool M., Shipley J.M.
Genes Chromosomes Cancer 48:455-467(2009).